Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-03

Clinical Trial Update: Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rezafungin for treatment of Pneumocystis pneumonia in adults with HIV is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rezafungin (rezafungin)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Pneumocystis Pneumonia | Phase 2 | Status: RECRUITING